GlassScriptPhysician profile
Geoffrey Stone
NPI 1679708952
$146,284.08
in general payments reported to CMS, 2019-2025
39 companies · $44K in 2025
The $44K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $4,084 · 2021: $11K · 2022: $15K · 2023: $35K · 2024: $20K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $64K · Travel and Lodging: $20K · Food and Beverage: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $64,120.00 |
| Travel and Lodging | $20,446.60 |
| Food and Beverage | $12,373.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,925.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $78,021.71 | 2019-2025 | Aetos Shoulder System, Real Intelligence, Twinfix |
| Anika Therapeutics, INC. | $24,386.51 | 2022-2023 | Revomotion, Drawtight, Ovomotion |
| Medacta USA, INC. | $19,391.35 | 2021-2025 | Mecta, Primary Shoulder, Reverse Shoulder |
| Encore Medical, LP | $8,188.03 | 2019-2025 | Djo Surgical |
| Stryker Corporation | $5,231.41 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Reunion |
| Arthrex, INC. | $4,239.62 | 2019-2023 | Shoulder Implants Biceps Repair Fibertak |
| Alon Medical Technology | $2,443.11 | 2019-2025 | |
| Xiros INC | $899.95 | 2022-2023 | Pitch-Patch, N/A |
| International Life Sciences | $843.12 | 2023-2024 | Flexband |
| Integrity Orthopaedics, INC. | $307.85 | 2025 | Integrity Orthopaedics |
| Depuy Synthes Sales INC. | $279.73 | 2019-2025 | Monovisc |
| Ossio INC | $257.82 | 2023 | |
| Medtronic USA, INC. | $239.51 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $215.60 | 2021-2024 | |
| Shoulder Innovations, INC. | $213.40 | 2023 | Inset System |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $167.58 | 2019-2023 | |
| Abbott Laboratories | $160.37 | 2024-2025 | Eterna, Proclaim |
| Fx Shoulder Solutions, INC | $152.02 | 2019-2025 | |
| Dunamis Medical, LLC | $135.48 | 2025 | |
| Catalyst Orthoscience | $78.77 | 2020 | |
| Innovation Technologies INC | $69.85 | 2024-2025 | Irrisept |
| Bioventus LLC | $49.10 | 2019-2022 | |
| Medtronic, INC. | $35.09 | 2024-2025 | Invos, Osteocool Rf Ablation System |
| Ultragenyx Pharmaceutical INC. | $29.72 | 2023 | |
| Amgen INC. | $25.84 | 2019 | |
| Biorez, INC. | $22.32 | 2022 | |
| Si-Bone, INC. | $19.85 | 2019 | |
| Forte Bio-Pharma LLC | $18.79 | 2021 | |
| Collegium Pharmaceutical, INC. | $17.95 | 2019 | |
| Paratek Pharmaceuticals, INC. | $17.21 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.77 | 2023 | Seglentis |
| Tactile Systems Technology INC | $15.88 | 2021 | |
| Melinta Therapeutics, LLC | $15.62 | 2019 | |
| Ermi LLC | $13.59 | 2020 | |
| Mallinckrodt Enterprises LLC | $13.35 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.30 | 2021 | |
| Ferring Pharmaceuticals INC. | $12.89 | 2019 | |
| Vericel Corporation | $12.42 | 2022 | |
| Pfizer INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geoffrey Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.